Skip to main content

Advertisement

Log in

Targeted percutaneous microwave ablation at the pulmonary lesion combined with mediastinal radiotherapy with or without concurrent chemotherapy in locally advanced non-small cell lung cancer evaluation in a randomized comparison study

Medical Oncology Aims and scope Submit manuscript

Abstract

Concurrent chemoradiotherapy is the standard treatment for patients with locally advanced lung cancer. The most common dose-limiting adverse effect of thoracic radiotherapy (RT) is radiation pneumonia (RP). A randomized comparison study was designed to investigate targeted percutaneous microwave ablation at pulmonary lesion combined with mediastinal RT with or without chemotherapy (ablation group) in comparison with RT (target volume includes pulmonary tumor and mediastinal node) with or without chemotherapy (RT group) for the treatment of locally advanced non-small cell lung cancers (NSCLCs). From 2009 to 2012, patients with stage IIIA or IIIB NSCLCs who refused to undergo surgery or were not suitable for surgery were enrolled. Patients were randomly assigned to the RT group (n = 47) or ablation group (n = 51). Primary outcomes were the incidence of RP and curative effectiveness (complete response, partial response, and stable disease); secondary outcome was the 2-year overall survival (OS). Fifteen patients (31.9 %) in the RT and two (3.9 %) in the ablation group experienced RP (P < 0.001). The ratio of effective cases was 85.1 versus 80.4 % for mediastinal lymph node (P = 0.843) and 83.0 versus 100 % for pulmonary tumors (P = 0.503), respectively, for the RT and ablation groups. Kaplan–Meier analysis demonstrated 2-year OS rate of NSCLC patients in ablation group was higher than RT group, but no statistical difference (log-rank test, P = 0.297). Percutaneous microwave ablation followed by RT for inoperable stage III NSCLCs may result in a lower rate of RP and better local control than radical RT treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.

    Article  CAS  PubMed  Google Scholar 

  2. Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, et al. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol. 2012;138:1475–86.

    Article  CAS  PubMed  Google Scholar 

  3. Shao Q, Li J, Li F, Wang S, Wang W, Liu S, et al. Clinical investigation into the initial diagnosis and treatment of 1168 lung cancer patients. Oncol Lett. 2015;9:563–8.

    PubMed Central  PubMed  Google Scholar 

  4. Shtivelman E, Hensing T, Simon GR, Dennis PA, Otterson GA, Bueno R, et al. Molecular pathways and therapeutic targets in lung cancer. Oncotarget. 2014;5:1392–433.

    PubMed Central  PubMed  Google Scholar 

  5. Chermiti Ben Abdallah F, Ben Ali G, Sadok Boudaya M, Mlika M, Chtourou A, Taktak S, et al. Treatment and prognosis of advanced stage non-small-cell lung cancer. Rev Mal Respir. 2014;31:214–20.

    Article  CAS  PubMed  Google Scholar 

  6. Al-Shahrabani F, Vallbohmer D, Angenendt S, Knoefel WT. Surgical strategies in the therapy of non-small cell lung cancer. World J Clin Oncol. 2014;5:595–603.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Chang JY, Kestin LL, Barriger RB, Chetty IJ, Ginsburg ME, Kumar S et al. ACR appropriateness criteria(R) nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intent. Oncology (Williston Park). 2014; 28: 706–10, 12, 14 passim.

  8. Laine AM, Westover KD, Choy H. Radiation therapy as a backbone of treatment of locally advanced non-small cell lung cancer. Semin Oncol. 2014;41:57–68.

    Article  PubMed  Google Scholar 

  9. Vansteenkiste J, De Ruysscher D, Eberhardt WE, Lim E, Senan S, Felip E et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013; 24 Suppl 6: vi89–98.

  10. Dang J, Li G, Zang S, Zhang S, Yao L. Comparison of risk and predictors for early radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with radiotherapy with or without surgery. Lung Cancer. 2014;86:329–33.

    Article  PubMed  Google Scholar 

  11. Selek U, Bolukbasi Y, Welsh JW, Topkan E. Intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy strategies for locally advanced non-small-cell lung cancer. Balkan Med J. 2014;31:286–94.

    Article  PubMed Central  PubMed  Google Scholar 

  12. de Baere T, Farouil G, Deschamps F. Lung cancer ablation: what is the evidence? Semin Interv Radiol. 2013;30:151–6.

    Article  Google Scholar 

  13. Yilmaz S, Adas YG, Hicsonmez A, Andrieu MN, Akyurek S, Gokce SC. Evaluation of the radiation pneumonia development risk in lung cancer cases. Asian Pac J Cancer Prev. 2014;15:7371–5.

    Article  PubMed  Google Scholar 

  14. Wei Z, Ye X, Yang X, Zheng A, Huang G, Li W, et al. Microwave ablation in combination with chemotherapy for the treatment of advanced non-small cell lung cancer. Cardiovasc Intervent Radiol. 2015;38:135–42.

    Article  PubMed  Google Scholar 

  15. Carrafiello G, Mangini M, Fontana F, Ierardi AM, De Marchi G, Rotolo N, et al. Microwave ablation of lung tumours: single-centre preliminary experience. Radiol Med. 2014;119:75–82.

    Article  PubMed  Google Scholar 

  16. Belfiore G, Ronza F, Belfiore MP, Serao N, di Ronza G, Grassi R, et al. Patients’ survival in lung malignancies treated by microwave ablation: our experience on 56 patients. Eur J Radiol. 2013;82:177–81.

    Article  CAS  PubMed  Google Scholar 

  17. Sonntag PD, Hinshaw JL, Lubner MG, Brace CL, Lee FT, Jr. Thermal ablation of lung tumors. Surg Oncol Clin N Am. 2011; 20: 369–87, ix.

  18. Brace CL, Hinshaw JL, Laeseke PF, Sampson LA, Lee FT Jr. Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology. 2009;251:705–11.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Acksteiner C, Steinke K. Percutaneous microwave ablation for early-stage non-small cell lung cancer (NSCLC) in the elderly: a promising outlook. J Med Imaging Radiat Oncol. 2015;59:82–90.

    Article  PubMed  Google Scholar 

  20. Yang X, Ye X, Zheng A, Huang G, Ni X, Wang J, et al. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases. J Surg Oncol. 2014;110:758–63.

    Article  PubMed  Google Scholar 

  21. Liu H, Steinke K. High-powered percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: a preliminary study. J Med Imaging Radiat Oncol. 2013;57:466–74.

    Article  CAS  PubMed  Google Scholar 

  22. Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg. 2009;15:4–9.

    PubMed  Google Scholar 

  23. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.

    Article  CAS  PubMed  Google Scholar 

  24. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.

    Article  CAS  PubMed  Google Scholar 

  25. Albain KS, Swann RS, Rusch VW, Turrisi AT 3rd, Shepherd FA, Smith C, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet. 2009;374:379–86.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Zarogoulidis K, Zarogoulidis P, Darwiche K, Boutsikou E, Machairiotis N, Tsakiridis K, et al. Treatment of non-small cell lung cancer (NSCLC). J Thorac Dis. 2013;5(Suppl 4):S389–96.

    PubMed Central  PubMed  Google Scholar 

  27. Ghaye B. Percutaneous ablation of malignant thoracic tumors. JBR-Btr. 2013;96:142–54.

    CAS  PubMed  Google Scholar 

  28. Roberton BJ, Liu D, Power M, Wan JM, Stuart S, Klass D, et al. Pulmonary ablation: a primer. Can Assoc Radiol J. 2014;65:177–85.

    Article  PubMed  Google Scholar 

  29. Sharma A, Abtin F, Shepard JA. Image-guided ablative therapies for lung cancer. Radiol Clin North Am. 2012;50:975–99.

    Article  PubMed  Google Scholar 

  30. Vogl TJ, Naguib NN, Gruber-Rouh T, Koitka K, Lehnert T, Nour-Eldin NE. Microwave ablation therapy: clinical utility in treatment of pulmonary metastases. Radiology. 2011;261:643–51.

    Article  PubMed  Google Scholar 

  31. Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol. 2006;17:1117–24.

    Article  PubMed  Google Scholar 

  32. Zheng A, Wang X, Yang X, Wang W, Huang G, Gai Y, et al. Major complications after lung microwave ablation: a single-center experience on 204 sessions. Ann Thorac Surg. 2014;98:243–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xinglu Xu.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, X., Ye, X., Liu, G. et al. Targeted percutaneous microwave ablation at the pulmonary lesion combined with mediastinal radiotherapy with or without concurrent chemotherapy in locally advanced non-small cell lung cancer evaluation in a randomized comparison study. Med Oncol 32, 227 (2015). https://doi.org/10.1007/s12032-015-0672-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-015-0672-1

Keywords

Navigation